Literature DB >> 22037823

Insights into Candida tropicalis nosocomial infections and virulence factors.

M Negri1, S Silva, M Henriques, R Oliveira.   

Abstract

Candida tropicalis is considered the first or the second non-Candida albicans Candida (NCAC) species most frequently isolated from candidosis, mainly in patients admitted in intensive care units (ICUs), especially with cancer, requiring prolonged catheterization, or receiving broad-spectrum antibiotics. The proportion of candiduria and candidemia caused by C. tropicalis varies widely with geographical area and patient group. Actually, in certain countries, C. tropicalis is more prevalent, even compared with C. albicans or other NCAC species. Although prophylactic treatments with fluconazole cause a decrease in the frequency of candidosis caused by C. tropicalis, it is increasingly showing a moderate level of fluconazole resistance. The propensity of C. tropicalis for dissemination and the high mortality associated with its infections might be strongly related to the potential of virulence factors exhibited by this species, such as adhesion to different host surfaces, biofilm formation, infection and dissemination, and enzymes secretion. Therefore, the aim of this review is to outline the present knowledge on all the above-mentioned C. tropicalis virulence traits.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 22037823     DOI: 10.1007/s10096-011-1455-z

Source DB:  PubMed          Journal:  Eur J Clin Microbiol Infect Dis        ISSN: 0934-9723            Impact factor:   3.267


  112 in total

1.  Adherence of Candida strains isolated from the human gastrointestinal tract.

Authors:  M Susana Biasoli; M Elena Tosello; H María Magaró
Journal:  Mycoses       Date:  2002-12       Impact factor: 4.377

2.  Phospholipase and proteinase activities in different Candida species isolated from anatomically distinct sites of healthy adults.

Authors:  Sukru Oksuz; Idris Sahin; Mustafa Yildirim; Aynur Gulcan; Tevfik Yavuz; Demet Kaya; Ayse Nedret Koc
Journal:  Jpn J Infect Dis       Date:  2007-09       Impact factor: 1.362

3.  Rapid identification of Candida species in oral rinse solutions by PCR.

Authors:  Giorgio Liguori; Angela Lucariello; Giuseppe Colella; Antonio De Luca; Paolo Marinelli
Journal:  J Clin Pathol       Date:  2007-09       Impact factor: 3.411

Review 4.  Hospital-acquired infections in the NICU: epidemiology for the new millennium.

Authors:  Alison J Carey; Lisa Saiman; Richard A Polin
Journal:  Clin Perinatol       Date:  2008-03       Impact factor: 3.430

Review 5.  A Candida-based view of fungal sex and pathogenesis.

Authors:  Richard J Bennett
Journal:  Genome Biol       Date:  2009-07-10       Impact factor: 13.583

6.  Prospective observational study of candidemia in São Paulo, Brazil: incidence rate, epidemiology, and predictors of mortality.

Authors:  Arnaldo L Colombo; Thaís Guimarães; Ligia R B F Silva; Leila Paula de Almeida Monfardini; Anna Karenine B Cunha; Patrícia Rady; Thelma Alves; Robert C Rosas
Journal:  Infect Control Hosp Epidemiol       Date:  2007-04-13       Impact factor: 3.254

7.  Comparison of results of fluconazole and voriconazole disk diffusion testing for Candida spp. with results from a central reference laboratory in the ARTEMIS DISK Global Antifungal Surveillance Program.

Authors:  Michael A Pfaller; Linda Boyken; Richard J Hollis; Jennifer Kroeger; Shawn A Messer; Shailesh Tendolkar; Daniel J Diekema
Journal:  Diagn Microbiol Infect Dis       Date:  2009-09       Impact factor: 2.803

8.  Fungemia in cancer patients in Brazil: predominance of non-albicans species.

Authors:  M Nucci; M I Silveira; N Spector; F Silveira; E Velasco; C A Martins; A Derossi; A L Colombo; W Pulcheri
Journal:  Mycopathologia       Date:  1998       Impact factor: 2.574

9.  Specific adherence of Candida tropicalis to lysophospholipids.

Authors:  A Prakobphol; H Leffler; S J Fisher
Journal:  Biochemistry       Date:  1994-08-16       Impact factor: 3.162

10.  Contamination, disinfection, and cross-colonization: are hospital surfaces reservoirs for nosocomial infection?

Authors:  Bala Hota
Journal:  Clin Infect Dis       Date:  2004-09-27       Impact factor: 9.079

View more
  29 in total

1.  Development of Echinocandin Resistance in Candida tropicalis following Short-Term Exposure to Caspofungin for Empiric Therapy.

Authors:  Ziauddin Khan; Suhail Ahmad; Eiman Mokaddas; Jacques F Meis; Leena Joseph; Aneesa Abdullah; Sandhya Vayalil
Journal:  Antimicrob Agents Chemother       Date:  2018-03-27       Impact factor: 5.191

Review 2.  The Candida pathogenic species complex.

Authors:  Siobhán A Turner; Geraldine Butler
Journal:  Cold Spring Harb Perspect Med       Date:  2014-09-02       Impact factor: 6.915

3.  Proteogenomics of Candida tropicalis--An Opportunistic Pathogen with Importance for Global Health.

Authors:  Keshava K Datta; Arun H Patil; Krishna Patel; Gourav Dey; Anil K Madugundu; Santosh Renuse; Jyothi E Kaviyil; Raja Sekhar; Aryashree Arunima; Bhavna Daswani; Inderjeet Kaur; Jyotirmaya Mohanty; Ranjana Sinha; Sangeeta Jaiswal; S Sivapriya; Yeshwanth Sonnathi; Bharat B Chattoo; Harsha Gowda; Raju Ravikumar; T S Keshava Prasad
Journal:  OMICS       Date:  2016-04

4.  Candida tropicalis antifungal cross-resistance is related to different azole target (Erg11p) modifications.

Authors:  A Forastiero; A C Mesa-Arango; A Alastruey-Izquierdo; L Alcazar-Fuoli; L Bernal-Martinez; T Pelaez; J F Lopez; J O Grimalt; A Gomez-Lopez; I Cuesta; O Zaragoza; E Mellado
Journal:  Antimicrob Agents Chemother       Date:  2013-07-22       Impact factor: 5.191

5.  Effect of Voriconazole on Candida tropicalis Biofilms: Relation with ERG Genes Expression.

Authors:  Tânia Fernandes; Sónia Silva; Mariana Henriques
Journal:  Mycopathologia       Date:  2016-06-03       Impact factor: 2.574

6.  Virulence Factors and Antifungal Susceptibility Profile of C. tropicalis Isolated from Various Clinical Specimens in Alexandria, Egypt.

Authors:  Mohammed A El-Kholy; Ghada F Helaly; Ebtisam F El Ghazzawi; Gamal El-Sawaf; Sherine M Shawky
Journal:  J Fungi (Basel)       Date:  2021-04-29

Review 7.  Prevalence of biofilms in Candida spp. bloodstream infections: A meta-analysis.

Authors:  María Belén Atiencia-Carrera; Fausto Sebastián Cabezas-Mera; Eduardo Tejera; António Machado
Journal:  PLoS One       Date:  2022-02-03       Impact factor: 3.240

8.  Epidemiology of invasive fungal infections in the intensive care unit: results of a multicenter Italian survey (AURORA Project).

Authors:  M T Montagna; G Caggiano; G Lovero; O De Giglio; C Coretti; T Cuna; R Iatta; M Giglio; L Dalfino; F Bruno; F Puntillo
Journal:  Infection       Date:  2013-03-06       Impact factor: 3.553

9.  The Candida Genome Database: the new homology information page highlights protein similarity and phylogeny.

Authors:  Jonathan Binkley; Martha B Arnaud; Diane O Inglis; Marek S Skrzypek; Prachi Shah; Farrell Wymore; Gail Binkley; Stuart R Miyasato; Matt Simison; Gavin Sherlock
Journal:  Nucleic Acids Res       Date:  2013-10-31       Impact factor: 16.971

10.  Candida glabrata among Candida spp. from environmental health practitioners of a Brazilian Hospital.

Authors:  Catarina Savastano; Elisa de Oliveira Silva; Lindyanne Lemos Gonçalves; Jéssica Maria Nery; Naiara Chaves Silva; Amanda Latercia Tranches Dias
Journal:  Braz J Microbiol       Date:  2016-03-02       Impact factor: 2.476

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.